Soligenix
SNGX
#10223
Rank
ยฃ12.18 M
Marketcap
ยฃ1.21
Share price
-1.23%
Change (1 day)
-51.81%
Change (1 year)

Soligenix (SNGX) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ7.9 Million

According to Soligenix's latest financial reports the company has ยฃ7.9 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Soligenix - Cash on Hand chart (from 1998 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ6.23 M-6.01%
2023-12-31ยฃ6.62 M-39.96%
2022-12-31ยฃ11.04 M-42.77%
2021-12-31ยฃ19.29 M40.81%
2020-12-31ยฃ13.7 M231.46%
2019-12-31ยฃ4.13 M-41.59%
2018-12-31ยฃ7.07 M22.48%
2017-12-31ยฃ5.77 M-18.72%
2016-12-31ยฃ7.1 M114.08%
2015-12-31ยฃ3.32 M-6.42%
2014-12-31ยฃ3.54 M-0.04%
2013-12-31ยฃ3.55 M70.97%
2012-12-31ยฃ2.07 M-46.18%
2011-12-31ยฃ3.85 M-20.07%
2010-12-31ยฃ4.82 M1.55%
2009-12-31ยฃ4.75 M372.17%
2008-12-31ยฃ1 M-9.92%
2007-12-31ยฃ1.11 M1729.71%
2006-12-31ยฃ0.06 M-87.18%
2005-12-31ยฃ0.47 M-60.78%
2004-12-31ยฃ1.21 M-47.22%
2003-12-31ยฃ2.3 M-11.01%
2002-12-31ยฃ2.58 M-62.28%
2001-12-31ยฃ6.85 M-20.33%
2000-12-31ยฃ8.6 M62.78%
1999-12-31ยฃ5.28 M-41.77%
1998-12-31ยฃ9.08 M-4.98%
1997-12-31ยฃ9.55 M
1996-01-31ยฃ0.67 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.18 B 2,232.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ7.84 B 99,202.63%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
ยฃ11.24 B 142,261.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ13.93 B 176,256.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
ยฃ0.76 M-90.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
ยฃ12.3 M 55.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.65 B 20,830.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel